Geranylgeranylacetone attenuates suppression by Helicobacter pylori extract of human umbilical vein epithelial cell growth

Hepato-Gastroenterology

Volumn 51, Issue 59, 2004, Pages 1558-1560

  Tatsuta, Masaharu ^a   Iishi, Hiroyasu ^a   Baba, Miyako ^a   Iseki, Kazushige ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Geranylgeranylacetone; Helicobacter pylori; Human umbilical vein epithelial cell growth

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIINFECTIVE AGENT; ANTIULCER AGENT; HELICOBACTER PYLORI VACCINE; TEPRENONE;

ANGIOGENESIS; ANTIBACTERIAL ACTIVITY; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; EPITHELIUM CELL; HELICOBACTER INFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UMBILICAL VEIN;

ANTI-ULCER AGENTS; ANTIGENS, BACTERIAL; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; DITERPENES; DRUG INTERACTIONS; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; HELICOBACTER PYLORI; HUMANS; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; UMBILICAL VEINS; UREA;

EID: 3342881872     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Tsuji S, Gunawan ES: Influences of Helicobacter pylori-urease on angiogenesis in vitro: implications for the bacterium in the delay of ulcer healing. Osaka Univ Med J 2000; 52:85-90.
2. Nagasawa Y, Ishikawa H, Iishi H, et al: Evaluation of gastric ulcer healing with mucosal microvascular architecture. Hepatogastroenterology 1998; 45:293-296.
3. Nagasawa Y, Tatsuta M, Iishi H, et al: Prevention of gastric ulcer recurrence by tetraprenylacetone. Scand J Gastroenterol 1998; 33:44-48.
4. Murakami M, Oketani K, Fujisaki H, et al: Antiulcer effect of geranylgeranylacetone, a new acyclic polisoprenoid on experimentally-induced gastric and duodenal ulcers in rats. Arzneim-Forsch 1981; 31:799-804.
5. Tanaka M, Hasegawa J, Tsutsumi J: Determination of the anti-ulcer agent geranylgeranylacetone in serum by gas chromatography-mass spectrometry. J Chromatog 1982; 231:301-310.
6. Murakami M, Oketani K, Fujisaki H, et al: Effects on the antiulcer drug geranylgeranylacetone on aspirin-induced gastric ulcer in rats. Jpn J Pharmacol 1982; 32:299-306.
7. Murakami M, Oketani K, Fujisaki H, et al: Effects of geranylgeranylacetone (GGA) on gastric lesions induced by topical aspirin plus HCl. Jpn J Pharmacol 1982; 32:921-924.
8. Arakawa T, Yamada H, Nakamura A, et al: Gastric cytoprotection by tetraprenylacetate in human subjects. Digestion 1988; 39:111-117.
9. Terano A, Hiraishi H, Ota S, et al: Geranylgeranylacetate, a novel antiulcer drug, stimulates mucus synthesis and secretion in rat gastric culture cells. Digestion 1986; 33:206-210.
10. Tatsuta M, Yamamoto R, Iishi H, et al: Scanning electron microscopic observations on gastric mucus secretion in rats, and the effects of tetraprenylacetate. Digestion 1995; 56:175-180.
11. Hirakawa T, Rokutan K, Nikawa T, et al: Geranylgeranylacetone induces heat shock protein in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 1996; 111:345-357.
12. Mizushima T, Tsutsumi S, Rokutan K, et al: Suppression of ethanol-induced apopttic DNA fragmentation geranylgeranylacetone in cultured guinea pig gastric mucosal cells. Dig Dis Sci 1999; 44:510-514.
13. Kalia N, Jones C, Bardhan KD, et al: Effects of genotypically different strains of Helicobacter pylori on human microvascular endothelial cells in vitro. Dig Dis Sci 2001; 46:54-61.
14. Snedecor GW, Cochran WG: Statistical methods. New York: McGraw-Hill, 1956.
15. Kurose I, Granger DN, Evans GJ, et al: Helicobacter pylori induced microvascular protein leakage in rats: Role of neutrophils, mast cells and platelets. Gastroenterology 1994; 104:7-79.
16. Kalia N, Jacob S, Brown NJ, et al: Studies on the gastric mucosal microcirculation. 2. Helicobacter pylori water soluble extracts induce platelet aggregation in the gastric muosal microcirculation in vivo. Gut 1997; 41:748-752.
17. Braquet P, Touqui L, Shen TY, et al: Perspective in platelet-activation factor research. Pharmacol Rev 1987; 39:97-145.
18. Tsuji S, Kawano S, Tsujii M, et al: Mucosal micocirculation and angiogenesis in gastrointestinal tract. Jpn J Clin Med 1998; 56:2247-2252.
19. Kurosawa A, Miwa H, Hirose M, et al: Helicobacter pylori induced injury in epithelial and gastric epithelial cells. Gastroenterology 2001; 32:320-326. (In Japanese)
20. Kurosawa A, Miwa H, Hirose M, et al: Effect of Helicobacter pylori water extract on proliferation and apoptosis in endothelial cells. Therap Res 2001; 22:S117-119.
21. Tsuji S: Effect of H. pylori on angiogenesis. Shokaki Ketsuryu no Kenkyu 1999; 15:23-30.
22. Hirose M, Watanabe S, Sato N: Effect of teprenone on restoration of vascular endothelial cell damage. Jpn J Gastroenterol 1999; 96:A169.